Showing results (51-60 of 89) with videos related to
Sort By:
Pageof 9
Diagnostics (Basel, Switzerland)|August 29, 2024
AI Digital Pathology Using qFibrosis Shows Heterogeneity of Fibrosis Regression in Patients with Chronic Hepatitis B and C with Viral ResponseFeng Liu, Yameng Sun, Dean Tai, et al.Hepatology International|April 2, 2024
Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessmentsShuyan Chen, Jialing Zhou, Xiaoning Wu, et al.Hepatology International|March 7, 2021
Comparison of fibrosis regression of entecavir alone or combined with pegylated interferon alpha2a in patients with chronic hepatitis BShuyan Chen, Jialing Zhou, Xiaoning Wu, et al.Stem Cell Research & Therapy|August 16, 2017
Inhibitory effects of HNF4α on migration/maltransformation of hepatic progenitors: HNF4α-overexpressing hepatic progenitors for liver repopulationPing Wang, Min Cong, Tianhui Liu, et al.BMJ Open Gastroenterology|October 14, 2015
Novel host genetic variations associated with spontaneous clearance of a single-source outbreak of HCV1b infectionsHong You, Sandu Liu, Yong Xie, et al.Viruses|May 27, 2023
The Impact of the Definitions of Clinical Phases on the Profiles of Grey-Zone Patients with Chronic Hepatitis B Virus InfectionXiaoqian Xu, Hao Wang, Shan Shan, et al.Biomaterials|April 22, 2025
Innovative sarcoma therapy using multifaceted nano-PROTAC-induced EZH2 degradation and immunity enhancementZhihao Chen, Yi Tai, Chuangzhong Deng, et al.Journal of Medical Virology|February 4, 2023
A new glutamine synthetase index to evaluate hepatic lobular restoration in advanced fibrosis during anti-HBV therapyShuyan Chen, Bingqiong Wang, Jialing Zhou, et al.Journal of Medical Virology|May 31, 2024
Long-term antiviral therapy is associated with changes in the profile of transcriptionally active HBV integration in the livers of patients with CHBXiajie Wen, Xiaoning Wu, Yameng Sun, et al.Hepatology (Baltimore, Md.)|April 26, 2023
Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneitiesWei Chen, Yameng Sun, Shuyan Chen, et al.Pageof 9